Estrogen plays a pivotal role in regulating functional adaptation of uteroplacental vessels in pregnancy. 17β-Estradiol (E2β) upregulates RYR2 and KCNMB1 expression and ryanodine receptor 2 (RyR2) and large-conductance Ca2+-activated K+ (BKCa) channel activity and subsequently enhances Ca2+ spark/STOC coupling, leading to reduced uterine arterial myogenic tone. E2β also increases production/release of nitric oxide (NO), hydrogen sulfide (H2S) and prostacyclin (PGI2) via upregulating the expression of NOS3, CBS and COX1 in uterine arteries. These vasodilators, through receptor or nonreceptor mechanisms to activate protein kinase A (PKA) and protein kinase G (PKG), promote vasodilation and blunt vasoconstriction, resulting in an overall decrease in uterine vascular tone.